News

Crohn’s Anti-TNF Tx Won’t Boost Cancer Risk

Anti-tumor necrosis factor agents like infliximab (Remicade) were not associated with risks for cancer in patients with Crohn’s disease, researchers found. Medscape (1/10)

More